Fatty Acids- Definition, Classification, Types,

Functions
Fats are a type of simple lipids, which are esters of fatty acid and glycerol,
and remain solid at room temperature.
A fatty acid is a component of lipids, which are made up of carboxylic acids
and a hydrocarbon side chain.
(Fatty Acid + Glycerol = Fats)

Fatty Acids
What are Fatty Acids?
• Fatty acids consist of a hydrophobic hydrocarbon chain with a terminal
carboxylic acid hence it is also termed aliphatic carboxylic acids.
• They occur in esterified form as well as a free fatty acid form.
• It is found in fats, oils, and other lipids In the esterified form.
• As free fatty acids (FFA) it is found unesterified in the plasma.
• Most of the fatty acids found in natural lipids contain even carbon atoms
(14C-20C). This is because the biosynthesis of fatty acids occurs with the
addition of 2 carbon units.
• Palmitic acid (16C) and stearic acid (18C) are most commonly found.
Classification of Fatty Acids
Saturated, Unsaturated fatty acids and Eicosanoids
• If the hydrocarbon chain of the fatty acid contains no double bond it is
termed saturated fatty acids since there is no room for any more
bonding.
• If the hydrocarbon chain of the fatty acid contains one or more double
bonds, it is termed unsaturated fatty acid
• Eicosanoids are derived from 20 carbon, polyenoic fatty acids, which are
made up of prostanoids, leukotrienes, and lipoxins.
• Fatty acids with one double bond are called monounsaturated fatty acid
• Fatty acids with two or more double bonds are called polyunsaturated
fatty acids (PUFA)
• In unsaturated fatty acids, the double bonds are generally spaced at three
carbon intervals.
• Most naturally occurring unsaturated fatty acids have the cis
configuration of double bonds
• The addition of a double bond decreases the melting temperature (Tm) of
the fatty acid.

Length of hydrocarbon chain

• Short-chain fatty acid contains less than 6 carbons in the hydrocarbon
chain
• It is termed medium-chain fatty acid if it contains 8- 14 carbons
• Long-chain fatty acid contains 16 -24 carbons in the hydrocarbon chain
• The melting temperature (Tm) of the fatty acid increases with the addition
of carbon atoms to the hydrocarbon chain.
Essential and non-essential fatty acids
• Essential fatty acids (EFA) are not synthesized by the body hence they
must be obtained from dietary sources
• Linoleic acid is a precursor of Omega-6 arachidonic acid.
• α-linolenic acid, a precursor of Omega-3 fatty acid
• Non-essential fatty acids are synthesized by a healthy body as long it gets
enough essential fatty acids.
• However, research shows the additional health benefits of direct
consumption of non-essential fatty acids as well.
Nomenclature of Fatty Acids
• The systematic nomenclature of the fatty acid is based on the
hydrocarbon it is derived from.
• The names of the saturated fatty acids end with a suffix -anoic (e.g.,
octanoic acid), whereas an unsaturated fatty acid’s name ends with a
suffix -enoic (e.g., octadecenoic acid).
• The numbering of carbon atoms begins from its carboxyl carbon, hence
the carboxy carbon is given the number 1. Adjacent carbon atoms are
numbered 2, 3, 4 so on. The second, third, and fourth carbons are also
referred to as α, β, and γ.
• The terminal carbon atom on the other end containing the methyl group
is referred to as Omega (ω) carbon. Carbon atoms are alternatively
numbered from the ω carbon side as ω1, ω2, ω3, ω4, etc.

Figure: Systematic nomenclature of fatty acids.

Trans Fats
• Trans fats are unsaturated fatty acids in which the double bond is
arranged in a trans configuration.
• Most naturally occurring unsaturated fatty acids in the body have double
bonds with cis configuration.
• Trans fatty acids arise primarily as an industrial source when edible oil
containing unsaturated fatty acid is partially hydrogenated. Additionally,
the unsaturated fatty acid in the rumen of ruminants like cows, goats, and
sheep is transformed by bacteria into trans fat.
• Trans fatty acids also arise when cooking oil is heated to a very high
temperature or when the cooking oil is repeatedly heated many times.
• Consumption of trans fats is associated with cardiovascular diseases,
diabetes mellites, colon cancer, etc.

Figure: Types of fatty acids.

Role of Fatty Acids
 • Fatty acid as a modulator of membrane properties:
• Prokaryotes, like bacteria, alter the fatty acid composition to maintain
membrane fluidity in response to temperature changes.
• The eukaryotic cell membrane is made up of a phospholipid bilayer, which
controls the transport of molecules to and for, regulates cellular
communications, and protects the cell from the surrounding environment.
• Energy supply and storage material:
• Fatty acids are used to produce neutral storage lipids like triglycerols (TAG),
Polyhydroxyalkanoates (PHA), and wax esters.
• Omega 3 PUFA (Polyunsaturated fatty acids) is required for normal
growth and functioning of the brain and retina.
• Docosahexaenoic acid (DHA) acts as a neurotrophic moderator,
modulates synaptic activity, involved in anti-inflammatory signaling.
• Biomarkers of organism:
• A certain fatty acid is specific to a member of a taxon of a bacterium as well
as a eukaryotic cell, additionally, fatty acids have structural diversity.
• Hence the presence of certain fatty acids and their ratio is a good
biomarker.
• Prokaryotes can be identified by their fatty acid fingerprint.
• The fatty acid markers are used to track energy fluxes in food webs.
Essential fatty acids (EFAs) are a type of polyunsaturated fat that the body cannot
produce and must be obtained from the diet for normal growth and health. The two
main EFAs are linoleic acid (an omega-6 fatty acid) and alpha-linolenic
acid (an omega-3 fatty acid). These EFAs serve as building blocks for cell
membranes and are converted into long-chain polyunsaturated fatty
acids (LCPUFAs) like arachidonic acid (AA), eicosapentaenoic acid (EPA), and
docosahexaenoic acid (DHA), which have various functions including regulating
inflammation and supporting brain and heart health.

Essential fatty acid (EFA)

The fatty acids that cannot be synthesised by the body and therefore should be
supplied in the diet are known as essential fatty acids. Chemically they are
polyunsaturated fatty acids (PUFA), namely linoleic acid, linolenic acid and
arachidonic acid.

Structure
CH3 (CH2)4 CH = CH-CH2-CH=CH(CH2)7 COOH
Linoleic acid
CH3 (CH2)4 CH = CH-CH2-CH=CH -CH2-CH = CH(CH2)7 COOH
Linolenic acid
CH3 (CH2)4 CH = CH-CH2-CH=CH -CH2-CH = CH-CH2-CH=CH-(CH2)3 COOH
Arachidonic acid
 Functions
• EFAs are requried for the membrane structure and [Link] are
necessary for the maintenance of growth, reproduction and good health.
• They are important for the transport of cholesterol, formation of lipoportein
and prevention of fatty liver.
• They serve as precursor for prostaglandin biosynthesis.
• They prolong clotting time and increase fibrinolytic activity.
What are EFAs?
• Definition:
EFAs are unsaturated fatty acids vital for cellular processes and human health that
the body cannot synthesize on its own.
• Necessity:
They are essential because they must be consumed through food or supplements
to meet the body's biological needs.
The Two Main EFAs
1. Linoleic Acid (LA):
This is an omega-6 fatty acid, and it is a precursor to other omega-6 fatty acids
like arachidonic acid (AA).
2. Alpha-Linolenic Acid (ALA):
This is an omega-3 fatty acid and a precursor to eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA).
Key Functions of EFAs
• Cell Membrane Structure:
EFAs are crucial structural components of all cell membranes, influencing their
fluidity and permeability.
• Precursors to Eicosanoids:
They are converted into vital regulatory molecules called eicosanoids (including
prostaglandins, thromboxanes, and leukotrienes), which play a role in processes
like immune response, inflammation, and blood vessel health.
• Brain and Heart Health:
Omega-3 EFAs (ALA, EPA, DHA) are particularly important for brain and heart
function.
Dietary Importance
• Dietary Sources:
 ALA is found in sources like flaxseed, chia seeds, and walnuts, while LA is found in
vegetable oils, according to Vedantu.
• Omega-3/Omega-6 Ratio:
The balance between omega-3 and omega-6 fatty acids in the diet is important
because of their competitive nature and distinct biological roles.
Conditionally Essential Fatty Acids
• While ALA and LA are the primary EFAs, some LCPUFAs like AA, EPA, and DHA
are considered conditionally essential. This means they become essential under
certain conditions, such as in human infants, when the body's ability to produce them
from the parent EFAs is insufficient.

What is a Phospholipid?
Phospholipids are a class of lipids composed of a hydrophilic head group, a glycerol
molecule, and two hydrophobic fatty acid tails. The hydrophilic head group consists of
various combinations of functional groups, such as choline, ethanolamine, serine, or
inositol, linked to the phosphate moiety. The fatty acid tails can be saturated or
unsaturated, and their composition determines the physical properties of the
phospholipid.

The plasma membrane that envelops cells is one of many biological membranes that
mostly consist of phospholipids. Phospholipids may form bilayers with their hydrophilic
head groups facing the aqueous environment on both sides because to the
hydrophobic nature of their fatty acid tails. With the help of this configuration,
chemicals may enter and leave cells in a controlled and selective manner.

Structure of Phospholipids
Phospholipids are amphipathic molecules, meaning they possess both hydrophilic
(water-loving) and hydrophobic (water-fearing) regions. This unique structure enables
 phospholipids to form the foundation of biological membranes. Let's explore the
detailed structure of phospholipids:

• Glycerol Backbone: Phospholipids consist of a glycerol molecule, which serves as

the central core of the molecule. The glycerol backbone contains three carbon
atoms, labeled as carbon 1, carbon 2, and carbon 3.
• Fatty Acid Tails: Two fatty acid tails are attached to the carbon atoms of the glycerol
backbone. The fatty acid tails are long hydrocarbon chains, typically consisting of 14
to 24 carbon atoms. These chains can be saturated, meaning they contain single
bonds between carbon atoms, or unsaturated, containing one or more double bonds.
• Phosphate Group: A phosphate group is attached to the third carbon atom (carbon
3) of the glycerol backbone. The phosphate group consists of a phosphorus atom
bonded to four oxygen atoms. One of these oxygen atoms is also bonded to the
glycerol backbone.
• Hydrophilic Head Group: The phosphate group is further linked to a hydrophilic head
group, which determines the specific type of phospholipid. The head group can vary
in composition and includes various functional groups, such as choline,
ethanolamine, serine, inositol, or others. The type of head group present gives rise
to different subclasses of phospholipids, such as phosphatidylcholine (PC),
phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylinositol
(PI), among others.

Phospholipid structure (Caballero et

al., 2003).

Phospholipids have a unique structure represented by a shorthand notation, indicating

the head group type and the fatty acid tails' carbon atom number and saturation. For
instance, PC (16:0/18:1) denotes a phosphatidylcholine molecule with a 16-carbon
saturated fatty acid tail (16:0) and an 18-carbon monounsaturated fatty acid tail (18:1).

Phospholipids play a crucial role in cell membranes, with their hydrophilic head group
interacting with the surrounding aqueous environment while facing outward.
Conversely, the hydrophobic fatty acid tails face inward, forming a hydrophobic core.
This unique arrangement allows phospholipids to spontaneously form a lipid bilayer,
which acts as a selective barrier regulating the movement of substances into and out
of the cell.

In addition to the basic structure, phospholipids can have various modifications and
substituents, such as acyl chains, sugar residues, or other functional groups. These
additional features contribute to the diversity and complexity of phospholipid structures
found in biological systems.

Functions of Phospholipids
Structural Role in Membranes: Phospholipids are the major building blocks of
biological membranes. They form a lipid bilayer structure in which the hydrophilic head
groups face the aqueous environment, while the hydrophobic fatty acid tails are
shielded from water. This arrangement provides structural integrity to cell membranes,
separating the internal contents of cells from their surroundings. Phospholipids also
contribute to the fluidity and flexibility of membranes, allowing for membrane dynamics
and cell movements.
Selective Permeability: The phospholipid bilayer acts as a selective barrier that
regulates the entry and exit of substances into and out of cells. The hydrophobic core
of the bilayer restricts the passage of hydrophilic molecules and ions, while small
hydrophobic molecules can diffuse through the lipid tails. This selective permeability
allows cells to maintain internal conditions, control the transport of essential molecules,
and prevent the entry of harmful substances.
Cell Signaling and Communication: Phospholipids play a key role in intracellular
signaling and communication processes in cells. Signals can be transmitted across cell
membranes more easily thanks to their use as platforms for the affixing and activation
of signaling proteins. Phospholipids like phosphatidylinositol 4,5-bisphosphate (PIP2)
are used to activate signaling pathways including the phosphoinositide signaling
cascade, which controls cell division, growth, and intracellular calcium signaling.
Energy Storage: Phospholipids can serve as a source of energy. When needed, the
fatty acid tails of phospholipids can be enzymatically cleaved from the glycerol
backbone through a process called lipolysis. This releases fatty acids that can be
further metabolized to generate energy through β-oxidation, providing fuel for cellular
processes.
Precursors for Bioactive Lipids: For the creation of bioactive lipid mediators, certain
phospholipids function as precursors. For instance, the precursor for the production of
prostaglandins, leukotrienes, and thromboxanes is arachidonic acid, which is released
from phospholipids like phosphatidylcholine or phosphatidylinositol. Inflammation,
immunological responses, and blood coagulation are just a few of the physiological
processes in which these lipid mediators play a role.
Membrane Protein Function: The insertion and stability of integral membrane
proteins take place in a phospholipid environment. Some phospholipids, such as
phosphatidylinositol phosphates, have the ability to interact directly with particular
membrane proteins, controlling their activity, location, and function.
Cellular Trafficking and Membrane Remodeling: Phospholipids take involved in
cellular activities involving membrane trafficking, including vesicle production,
exocytosis, and endocytosis. In addition, they participate in membrane remodeling
processes such membrane fusion and fission, which are essential for cell division,
organelle dynamics, and intracellular transport.
Cellular Signatures and Recognition: In order to differentiate one cell type from
another, phospholipids can serve as biological signatures by supplying distinctive lipid
profiles. These lipid profiles may have an impact on processes including immunological
responses, tissue formation, and cell migration by affecting cell recognition and cell-
cell interactions.

Applications of Phospholipids
Drug Delivery Systems: Phospholipids are widely used in the formulation of liposomes,
which are microscopic vesicles composed of lipid bilayers. Liposomes can encapsulate
drugs, allowing targeted and controlled release at specific sites in the body. They are
employed in drug delivery systems for improved therapeutic efficacy and reduced side
effects.

Biotechnology: Phospholipids are necessary for biotechnological procedures including

protein expression and cell culture. They allow the creation of recombinant proteins
and offer a stable environment for cell development.

Food and Cosmetics: Phospholipids are used as emulsifiers and stabilizers in food and
cosmetic products. They improve texture, shelf life, and sensory properties while
ensuring proper formulation stability.

Research Tools: Phospholipids are useful for study, especially when looking at
membranes and lipid-protein interactions. Modeling biological membranes,
constructing artificial lipid bilayers, and researching membrane-related processes all
involve their utilization.

What are Phospholipid Bilayers?

The phospholipid bilayer is a key structural component of biological membranes. Two
layers of phospholipid molecules make up this bilayer, with the hydrophilic heads
facing the internal and exterior aquatic surroundings and the hydrophobic tails facing
one another in the middle. This design successfully separates the interior and exterior
of cells by forming a durable, self-sealing barrier.

The phospholipid bilayer not only provides a structural framework but also plays a
crucial role in the organization and functionality of membranes. It serves as a platform
for the incorporation of proteins and other lipids, facilitating their proper distribution and
spatial arrangement within the membrane. This organization is essential for the
functioning of membrane proteins, which rely on specific localization for their
interactions and activities.

Furthermore, the phospholipid bilayer's fluid nature allows for the lateral movement of
molecules within the membrane. This fluidity contributes to the flexibility and dynamic
nature of biological membranes, enabling processes such as membrane fusion,
endocytosis, and exocytosis. Membrane fusion involves the merging of lipid bilayers,
allowing the exchange of materials between compartments. Endocytosis and
exocytosis are cellular processes that involve the internalization and secretion of
molecules through membrane-bound vesicles, respectively.
Phospholipid bilayer composed of hydrophobic non-polar tails and hydrophilic polar heads
(Belhocine et al., 2011)

Sphingolipid Structure and Classification

Sphingolipids derive their name from the backbone structure known as "sphingoid
base," which is a long-chain amino alcohol. The most common sphingoid base is
sphingosine, but others, such as dihydrosphingosine and phytosphingosine, also exist.
These backbones differentiate sphingolipids from other lipid classes like
glycerophospholipids and cholesterol derivatives.

Sphingolipids can be classified based on their complexity and the presence of

additional functional groups. The major classes include ceramides, sphingomyelins,
cerebrosides, gangliosides, and sphingosine-1-phosphate (S1P). Each class
possesses unique structural and functional characteristics, making them vital players in
various cellular processes.

Ceramides: Ceramides are the simplest form of sphingolipids, composed of a

sphingoid base and a single fatty acid linked by an amide bond. They serve as
precursors for more complex sphingolipids and are involved in cellular signaling
pathways related to apoptosis and stress responses.

Sphingomyelins: Sphingomyelins consist of a sphingoid base, a fatty acid, and a

phosphorylcholine or phosphorylethanolamine head group. These lipids are abundant
in cell membranes, especially in myelin sheaths, where they contribute to the stability
and insulation of nerve cells.

Cerebrosides: Cerebrosides contain a sphingoid base, a fatty acid, and a single sugar
residue. They are commonly found in the nervous system and are crucial for
maintaining the integrity of neuronal cell membranes.

Gangliosides: Gangliosides are the most complex sphingolipids, containing multiple

sugar residues in addition to a sphingoid base and a fatty acid. These lipids are
predominantly present in the nervous system and participate in cell-to-cell recognition
and signaling.

Sphingosine-1-phosphate (S1P): S1P is a phosphorylated sphingoid base that acts as

a potent bioactive lipid mediator involved in various cellular processes, including cell
migration, proliferation, and immune responses.
Sphingolipids and phospholipids: The classification of sphingolipids is based on the group
attached to the sphingosine (LCB) backbone (Kukwa et al., 2021)

Sphingolipid vs. Phospholipid: A Comparative

Analysis
Sphingolipids and phospholipids are both essential components of cell membranes,
but they exhibit significant differences in structure and function. Let's explore some of
the key distinctions between these two lipid classes:

Backbone Structure: Sphingolipids have a sphingoid base backbone, while

phospholipids have a glycerol backbone. The presence of the unique sphingoid base
gives sphingolipids distinct physicochemical properties.

Fatty Acid Attachment: In sphingolipids, the fatty acid is linked to the sphingoid base
via an amide bond. In phospholipids, the fatty acids are attached to the glycerol
backbone through ester linkages.

Polarity: Sphingolipids are generally less polar than phospholipids due to the absence
of a charged phosphate group in their structure.

Cellular Location: Sphingolipids are enriched in specific membrane domains known as

lipid rafts, where they play roles in signal transduction and protein trafficking.
Phospholipids are distributed throughout the entire cell membrane and participate in
membrane fluidity and stability.

Functions: Sphingolipids are involved in diverse cellular processes, including

apoptosis, cell adhesion, and cell signaling. Phospholipids are primarily involved in
forming the lipid bilayer and compartmentalization of cellular organelles.

Despite these differences, sphingolipids and phospholipids work synergistically to

maintain cellular homeostasis and perform crucial functions within cells.

Sphingolipid Metabolism
Sphingolipid metabolism involves a series of intricate and highly regulated enzymatic
reactions that govern the biosynthesis, degradation, and recycling of sphingolipids.
This metabolic pathway plays a crucial role in maintaining cellular homeostasis and is
tightly linked to various cellular processes, including cell growth, differentiation,
apoptosis, and immune responses.

Sphingolipid Biosynthesis
The biosynthesis of sphingolipids begins with the condensation of palmitoyl-CoA and
serine to form 3-keto-dihydrosphingosine (3-keto-DHS). This critical reaction is
catalyzed by the enzyme serine palmitoyltransferase (SPT) and represents the rate-
limiting step in sphingolipid biosynthesis. The subsequent steps involve the reduction
of 3-keto-DHS to dihydrosphingosine (DHS), followed by acylation to form
dihydroceramide. The acylation step is catalyzed by dihydroceramide synthase.
Finally, dihydroceramide is desaturated by dihydroceramide desaturase to form
ceramide, which serves as the backbone for the synthesis of more complex
sphingolipids.

Sphingolipid Catabolism
Sphingolipid catabolism mainly occurs in lysosomes and involves the breakdown of
sphingolipids into simpler components, which can be recycled for further use. This
process is mediated by specific enzymes known as sphingolipid hydrolases, including
sphingomyelinases, ceramidases, and glycosidases.

Sphingomyelinases: These enzymes hydrolyze sphingomyelin, a sphingolipid present

in the cell membrane, into ceramide and phosphorylcholine. Sphingomyelinases play
roles in cellular stress responses and the regulation of membrane properties.

Ceramidases: Ceramidases catalyze the hydrolysis of ceramide into sphingosine and a

fatty acid. This reaction generates the bioactive lipid sphingosine, which is involved in
various cellular processes, including cell apoptosis and immune regulation.

Glycosidases: Glycosidases cleave the sugar residues from complex

glycosphingolipids, generating ceramide as a product. This step is critical for the
recycling of sphingolipids and the regeneration of ceramide for further use in
sphingolipid biosynthesis.

Sphingolipid Recycling and Salvage Pathways

The catabolism of sphingolipids generates simple components, such as ceramide and
sphingosine, which can be recycled to produce new sphingolipids. This recycling
process, known as the "sphingolipid salvage pathway," ensures efficient utilization of
sphingolipid building blocks and maintains cellular sphingolipid levels.

Ceramide, generated through sphingolipid catabolism, can be re-acylated to form

ceramide-1-phosphate, a precursor for the synthesis of complex sphingolipids, such as
sphingomyelins and glycosphingolipids.

Sphingosine, produced by the hydrolysis of ceramide, can be phosphorylated to

sphingosine-1-phosphate (S1P) by sphingosine kinase. S1P is a potent bioactive lipid
mediator that participates in various cellular processes, including cell migration,
proliferation, and immune responses. S1P also serves as an important signaling
molecule in the sphingolipid signaling pathway.

The recycling and salvage pathways are essential for maintaining the proper balance
of sphingolipids within cells and ensuring their involvement in vital cellular functions.
 Pathways of sphingolipid metabolism and key enzymes (Ogretmen et al., 2018).

Glycolipids
Glycolipids are components of cellular membranes comprised of a hydrophobic lipid tail and
one or more hydrophilic sugar groups linked by a glycosidic bond. Generally, glycolipids are
found on the outer leaflet of cellular membranes where it plays not only a structural role to
maintain membrane stability but also facilitates cell-cell communication acting as receptors,
anchors for proteins and regulators of signal transduction [1]. Glycolipids are found widely
distributed throughout all cells and primarily localized, but not exclusively, to the plasma
membrane.

Structure and Synthesis

The basic structure of a glycolipid consists of a mono- or oligosaccharide group attached to a
sphingolipid or a glycerol group (can be acetylated or alkylated) with one or two fatty acids.
These make up the classes of glycosphingolipids and glycoglycerolipids, respectively.
Glycolipids interact and bind to the lipid-bilayer through the hydrophobic nature of the lipid
tail which anchors it to the surface of the plasma membrane.

Figure 1.4.1. Structure of glycolipids

Synthesis of glycolipids proceed by a series of enzymes that sequentially add sugars to the
lipid. Glycosphingolipids are derived from lactosylceramide (LacCer; β-D-galactosyl(1→4)-
β-D-glucosyl-ceramide) where the first step is the acylation and desaturation of D-erythro-
sphinganine. Ceramide is glucosylated then β-galactosylated extracellularly to form
lactosylceramide. Further elongation can occur via glycosyltransferases and sulfotransferases.
For example, the biosynthesis of a major glycoglycerolipid in plants involves the transfer of a
galactosyl from UDP-Gal onto diacylglycerol to produce β-galactosyldiacylglycerol via
galactosyltransferases. An additional transfer of a galactosyl from UDP-Gal forms α-D-
galactosyl-(1,6)-O-β-D-galactosyldiacylglycerol [2].

Metabolism
Degradation of glycosphingolipids are mediated by internalization by endocytosis. They are
transported to the lysosomes where enzymes degrade the glycosphingolipids through
hydrolytically and irreversible cleavage of bonds. Sphingolipidoses, which are present in the
membrane, also mediate the degradation of these class of glycolipids [4].

Dysfunction of glycolipid metabolism is linked to several different diseases from the

disruption of glycolipid degradation leading to the accumulation of glycolipids.
Figure 1.4.2 illustrates diseases associated with different disruptions in the metabolism of
glycolipids. For example, Tay-Sachs disease is an autosomal recessive disease that is a
member of the GM2 gangliosidotic disease. The disease portrays symptoms of severe psycho-
motor developmental disordered which is caused by the inabiligy to properly degrade
membrane associated gangliosides. This occurs because the enzyme required to break down
gangliosides, β-hexosamindase A, is dysfunctional due to mutations in the HEXA gene. The
accumulation of these gangliosides in the neurons results in neural cell death.

Figure 1.4.2.
Diseases associated with dysfunction of glycolipid metabolism

Distribution
The majority of glycolipids are located in membrane structures in the cell. Two-thirds of total
glycolipids are distributed in intracellular membranes such as the golgi-apparatus,
endosomes, lysosomes, nuclear membrane, and mitochondria [4]. Glycolipids are synthesized
in the golgi-apparatus where the majority are transported to membranes to maintain the
bilayer. Few glycolipids can be found in the cystol; approximately 5% of the total glycolipids
in the brain are found in the soluble fraction.

Glycosphingolipids in the plasma membrane can cluster with cholesterol to for rafts which
contains less phospholipids relative to other portions of the membrane; approximately 70% of
total glycolipids are found in these rafts which form hydrophobic interactions [5]. In addition,
sphingolipids and glycosphingolipids form weak interactions between the carbohydrate head
groups and the hydrophobic saturated side chain lipids with cholesterol filling any voids [6].
The strong interactions between glycolipids and cholesterol is the driving force which
segregates them from the fluid phospholipids in the membrane [7].

Function
Carbohydrates on glycolipids are the most exposed structures on the extracellular surface of
cells and are flexible with numerous binding sites which make them optimal for cell
signaling. Since the lipid moiety is usually buried within the membrane, carbohydrate-
carbohydrate interactions are the predominant interactions that may occur between
glycolipids. They can interact side by side within the same membrane or trans interactions
between two membranes. Trans interactions between glycolipids was reported to be the basis
for glycosphingolipid-dependent cell to cell adhesion which involves calcium ions [8].
Further studies reported that cell surface carbohydrates play major roles in cell-substrate
recognition in oncogenesis, myelin sheath regulation, and cell adhesion in metastasis [9-11].
Glycolipids play an important role in several biological functions such as recognition and cell
signaling events; below are a few biological functions glycolipids play a role in.

Signal Transduction

Glycosphingolipids and sphingomyelin are clustured into microdomains where they can
associate with serveral different proteins such as cSrc, G-proteins, and focal adhesion kinase
to mediate cellular events [12]. In the plasma membrane, glycosphingolipids form rafts with
cholesterol where these regions have relatively less phospholipids. Shown in Figure 1.4.3,
glycosphingolipids form rafts with cholestorol to anchor GPI proteins to the extracellular
leaflet and src family kinases to the cystolic leaflet. Thus, glycosphingolipids have been
These microdomains can cause cellular responses by associating with GPI-anchored proteins
which may induce activation of specific kinases to transduce the phosphorylation of different
substrates [13]. The glycosphingolipid microdomains have also been associated with
mediating immunoreceptors and growth factor receptors [14].
Cell Proliferation

Glycolipids have been observed to play a role in the regulation of cell growth via interactions
with growth factor receptors. Intracellular ceramide stimulated DNA synthesis in endothelial
smooth muscle cells and also induced mitogenesis by platelet-derived growth factor [15].
Lactosylceramide activates NADPH oxidase to modulate interacellular adhesion molecule -1
expression on human umbilical vein endotheial cells and to induce proliferation of human
aortic smooth muscle cells. With the reduction of ceramide, there was increased ceramidase
activity, sphingomyelin synthase which is associated with the proliferation of smooth muscle
cells. In addition, gangliosides are known to be involved in inducing apoptosis. Apoptotic
signal triggered by CD95 in lymphoid and myeloid tumor cells increase ceramide levels
which results in the increase in ganglioside GD3 synthesis; GD3 is known to be a potent
mediatior of cell death. Abundant amounts of glycosphingolipids are found in the plasma
membrane of cancer cells where antibodies targeting these gangliosides result in apoptosis
[16]. Treatment with anti-ganglioside GD2 monoclonal antibodies induces apoptosis in GD2
expressing human lung cancer cells.

Calcium Signaling

Gangliosides are associated with calcium ions which is thought to have a role in neuronal
function. Ganglioslide micelles bind to calcium ions with high affinity and may play a
significant role in synaptic transmission. It has been reported that sphingosine and ceramide
mediate the release of calcium from intracellular stores. Gangliosides may also play a role in
calcium homeostasis and signaling. These glycolipids induce changes in cellular calcium
through the modulation ofcalcium influx channels, calcium exchange proteins, and calcium
dependent enzymes which were altered through the association of gangliosides. [17]. In
addition, increased levels of intracellular glucosylceramide resulted in increased calcium
stores in neurons [18]. Glycolipid galactocerebroside have been observed in the opening of
calcium channels in oligodendrocyte cells.

Types of Glycolipids
Glycosphingolipids

Glycosphingolipids are a class of glycolipids which contain ceramide as the lipid complex.
Ceramides are amides of fatty acids with long chain di- or trihydroxy bases. The acyl group
of ceramides is a long chain saturated or monounsaturated fatty acids. These lipids are
primarily found in nerve tissue nerve tissue and mediate cell signaling. The glycophingolipids
can be subdivided into the following groups:

1. Neutral glycosphingolipids: Cerebrosides also known as monoglycosylceramides are

glycolipids primarily found in the brain and peripheral nervous tissue. The most
common cerebroside contains a molecule of galactose found in myelin. Their function
is to provide a protective coating to each nerve acting as an insulator with high
concentrations in the myelin sheath.
2. Acidic glycosphingolipids: These lipids are negatively charged at physiological pH
which is provided by N-acetylneuraminic acid (NANA) or by sulfate groups in
sulfatides. Gangliosides contain a sialic acid (NANA) making them negatively
charged. These are found in the ganglion cells of the CNS and are predominantly at
nerve endings. Sulfatides are sulfated galactocerebrosides which are found in the
brain and kidneys. They are primarily found in the medulated nerve fibers and have
been linked to immune responses to nervous system signaling.
3. Basic glycosphingolipids
4. Amphoteric glycosphingolipids
Glycoglycerolipids

1. Neutral glycoglycerolipids: These usually contain one or two sugars linked to

glycerol or diacylglycerol. These lipids have important roles in higher plants, algae,
and bacteria in which they are localized to photosynthetic membranes. Photosynthetic
membranes are comprised of about 85% of neutral glycoglycerolipids [6]. neutral
glycoglycerol lipids can be separated into non-acylated or acylated glycoside
moieties.
2. Glycophospholipids: These compounds are glycoglycerolipids containing at least one
phosphate group attached to either the sugar or glycerol. The simpliest of these
compounds are found in red blood cells called glucosylated phosphatidic acid.
3. Sulfoglycoglycerolipids: These compounds contain a sulfur atom and are proposed to
be localized to acidic membranes (surface membrane strongly acidic). Sulfolipids are
shown to be present in the thylakoid membranes of plants within the photosynthetic
membranes.
What are Gangliosides?
Gangliosides are a class of complex glycosphingolipids that are primarily found in the
outer leaflet of the plasma membrane of animal cells, particularly abundant in nervous
tissue. Structurally, gangliosides consist of a ceramide lipid backbone attached to a
carbohydrate portion, which includes one or more sialic acid residues. The presence of
sialic acid residues distinguishes gangliosides from other glycosphingolipids.
Gangliosides play critical roles in cell signaling, recognition, adhesion, and membrane
stability, particularly in the nervous system, where they are involved in neuronal
development, synaptic transmission, and plasticity. They are also implicated in various
physiological processes outside the nervous system, including cell adhesion,
migration, immune cell activation, and lipid metabolism. Dysregulated ganglioside
metabolism has been associated with a wide range of diseases, including
neurodegenerative disorders, cancer, metabolic disorders, and infectious diseases.
 Structure of gangliosides (Park
et al., 2020)

Biosynthesis of Gangliosides
Gangliosides are synthesized through a series of intricate enzymatic reactions within
the Golgi apparatus of cells. The biosynthesis pathway involves the stepwise addition
of specific sugar residues onto a ceramide backbone, ultimately leading to the
formation of various ganglioside species.

Overview of Ganglioside Biosynthesis Pathway

Ceramide Synthesis: The biosynthesis of gangliosides initiates with the generation of
ceramide, a lipid molecule composed of sphingosine and a fatty acid. Ceramide serves
as the backbone onto which sugar residues are attached to form gangliosides.
Formation of Glucosylceramide: The first step in ganglioside synthesis involves the
addition of a glucose residue to ceramide, catalyzed by the enzyme glucosylceramide
synthase. This reaction produces glucosylceramide, which serves as the precursor for
complex ganglioside structures.
Elaboration of the Sugar Chain: Subsequent enzymatic reactions mediated by
glycosyltransferases lead to the stepwise addition of additional sugar residues, such as
galactose and N-acetylglucosamine, onto the glucosylceramide backbone. These
reactions result in the formation of various intermediate glycosphingolipids, including
lactosylceramide and ganglioside precursors.
Sialylation: The defining characteristic of gangliosides is the presence of sialic acid
residues on their carbohydrate chains. Sialylation, catalyzed by sialyltransferases,
involves the transfer of sialic acid residues onto precursor gangliosides, leading to the
generation of complex ganglioside structures with different sialic acid linkages (e.g.,
α2-3, α2-6).
Maturation and Diversification: Further modifications, such as acetylation and
sulfation, may occur on the sialic acid residues of gangliosides, leading to the
generation of structurally diverse ganglioside species. These modifications influence
the physicochemical properties and biological functions of gangliosides.

Key Enzymes and Reactions in the Biosynthesis Pathway

• Glucosylceramide Synthase: This enzyme catalyzes the transfer of glucose from
UDP-glucose to ceramide, generating glucosylceramide as the first intermediate in
ganglioside biosynthesis.
• GM2/GD2 Synthase: GM2/GD2 synthase, encoded by the B4GALNT1 gene, is
responsible for catalyzing the transfer of N-acetylgalactosamine (GalNAc) to
lactosylceramide, leading to the formation of GM2 and GD2 gangliosides.
• GM3 Synthase: GM3 synthase, encoded by the ST3GAL5 gene, catalyzes the
addition of sialic acid to lactosylceramide, producing GM3 ganglioside, the simplest
ganglioside structure.
 Regulation Mechanisms and Influencing Factors of Biosynthesis
Ganglioside biosynthesis is tightly regulated at multiple levels to maintain cellular
homeostasis and meet physiological demands. The expression and activity of key
biosynthetic enzymes are regulated by various factors, including:

Transcriptional Regulation: The expression of genes encoding ganglioside

biosynthetic enzymes is regulated by transcription factors and signaling pathways in
response to developmental cues, environmental stimuli, and pathological conditions.
Post-translational Modifications: Enzyme activity and localization can be modulated
by post-translational modifications such as phosphorylation, glycosylation, and
proteolytic cleavage.
Substrate Availability: The availability of precursors, such as ceramide and sugar
nucleotides, influences the rate and extent of ganglioside biosynthesis. Alterations in
substrate availability due to metabolic changes or nutrient availability can impact
ganglioside levels.
Cellular Differentiation and Development: Ganglioside expression patterns undergo
dynamic changes during cellular differentiation and development, reflecting the specific
requirements of different cell types and tissues.
Pathological Conditions: Dysregulation of ganglioside biosynthesis is associated with
various pathological conditions, including neurodegenerative diseases, cancer, and
metabolic disorders. Aberrant expression of biosynthetic enzymes contributes to
disease pathogenesis and progression.
Understanding the regulatory mechanisms governing ganglioside biosynthesis is
essential for elucidating their roles in health and disease and may provide insights into
therapeutic interventions targeting ganglioside metabolism.

Select Services
• Gangliosides Analysis Service
• Ceramides Analysis Service
• Lipidomics Service

Physiological Functions of Gangliosides

Roles and Importance of Gangliosides in the Nervous System
Neuronal Development and Differentiation: Gangliosides are essential for proper
neuronal development, including neurite outgrowth, axon guidance, and
synaptogenesis. They regulate the formation and stabilization of neuronal connections
during embryonic development and postnatal maturation.
Synaptic Transmission and Plasticity: Gangliosides modulate synaptic transmission
by regulating the localization and function of neurotransmitter receptors, ion channels,
and synaptic vesicle trafficking proteins. They play crucial roles in synaptic plasticity,
including long-term potentiation (LTP) and long-term depression (LTD), which underlie
learning and memory processes.
Axonal Growth and Myelination: Gangliosides are involved in promoting axonal
growth and guiding axonal pathfinding during neural circuit formation. They also
participate in myelination, the process by which oligodendrocytes and Schwann cells
wrap axons with myelin sheaths, facilitating rapid and efficient signal transmission
along neuronal fibers.
Neuronal Survival and Apoptosis: Gangliosides regulate neuronal survival and
apoptosis by modulating intracellular signaling pathways involved in cell survival, such
as the PI3K/Akt and MAPK/ERK pathways. They protect neurons from apoptotic stimuli
and promote cell viability under physiological and pathological conditions.

Relationship between Gangliosides and Cell Signaling

Modulation of Receptor Function: Gangliosides interact with various cell surface
receptors, including growth factor receptors, cytokine receptors, and neurotransmitter
receptors, modulating their activity and downstream signaling pathways. They regulate
receptor clustering, internalization, and intracellular trafficking, thereby influencing
cellular responses to extracellular cues.
Activation of Intracellular Signaling Pathways: Gangliosides serve as signaling
molecules by activating intracellular signaling cascades, including protein kinase C
(PKC), mitogen-activated protein kinase (MAPK), and phosphoinositide 3-kinase
(PI3K) pathways. They regulate cellular processes such as proliferation, differentiation,
and survival by modulating gene expression and protein synthesis.
Integration with Lipid Rafts: Gangliosides are enriched in lipid rafts, specialized
membrane microdomains that serve as platforms for signal transduction and
membrane trafficking. They organize and stabilize lipid raft structures, facilitating the
assembly and activation of signaling complexes involved in cell signaling and
membrane dynamics.

Functions in Other Tissues and Systems

Cell Adhesion and Migration: Gangliosides participate in cell-cell and cell-
extracellular matrix adhesion by interacting with adhesion molecules, such as integrins
and cadherins. They regulate cell migration, invasion, and metastasis in various
physiological and pathological contexts, including embryonic development, immune
response, and cancer progression.
Immune Cell Activation and Regulation: Gangliosides modulate immune cell
functions by acting as ligands for immune receptors and signaling molecules. They
regulate immune cell activation, proliferation, and cytokine production, influencing
immune responses to pathogens, tumors, and inflammatory stimuli.
Lipid Metabolism and Insulin Sensitivity: Gangliosides are implicated in lipid
metabolism and insulin sensitivity, with dysregulated ganglioside levels being
associated with obesity, diabetes, and metabolic syndrome. They regulate lipid droplet
formation, adipocyte differentiation, and insulin signaling pathways, affecting whole-
body energy homeostasis and glucose metabolism.

Association of Gangliosides with Diseases

Gangliosides, being critical components of cellular membranes and key regulators of
signaling pathways, are implicated in various physiological and pathological processes.
Dysregulation of ganglioside metabolism has been linked to the pathogenesis and
progression of numerous diseases, including neurological disorders, cancer, metabolic
disorders, and infectious diseases.

Roles of Gangliosides in Neurological Disorders

Neurodegenerative Diseases: Gangliosides are involved in the pathogenesis of
neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease
(PD), and Huntington's disease (HD). Alterations in ganglioside composition and
distribution contribute to neuronal dysfunction, synaptic loss, and neuroinflammation
observed in these disorders.
Neurodevelopmental Disorders: Gangliosides play critical roles in
neurodevelopmental disorders, such as autism spectrum disorders (ASD) and
intellectual disabilities. Aberrant ganglioside expression during brain development can
disrupt neuronal migration, synaptogenesis, and circuit formation, leading to cognitive
and behavioral deficits.

Associations with Other Diseases and Research Advances

Cancer: Gangliosides are implicated in cancer progression and metastasis by
promoting tumor cell proliferation, survival, and invasion. Elevated levels of
gangliosides, particularly GD2 and GD3, are observed in various cancer types,
including melanoma, neuroblastoma, and breast cancer. Targeting ganglioside-
dependent signaling pathways represents a promising strategy for cancer therapy.
Metabolic Disorders: Dysregulated ganglioside metabolism is associated with
metabolic disorders, such as obesity, diabetes, and metabolic syndrome. Altered
ganglioside levels in adipose tissue and skeletal muscle contribute to insulin
resistance, inflammation, and lipid accumulation, predisposing individuals to metabolic
complications.
Infectious Diseases: Gangliosides serve as receptors or co-receptors for pathogens,
facilitating host-cell recognition and entry. Binding of bacterial toxins, viruses, and
parasites to gangliosides on host cell membranes can trigger cellular damage,
inflammation, and tissue injury, contributing to the pathogenesis of infectious diseases.

Potential Therapeutic and Diagnostic Applications

Therapeutic Targeting: Modulation of ganglioside metabolism represents a promising
therapeutic approach for treating various diseases. Strategies aimed at inhibiting
ganglioside synthesis, targeting ganglioside-dependent signaling pathways, or
enhancing ganglioside clearance may offer novel therapeutic interventions for
neurological disorders, cancer, and metabolic diseases.
Diagnostic Biomarkers: Alterations in ganglioside expression patterns are potential
diagnostic biomarkers for disease detection and prognosis. Detection of specific
ganglioside profiles in biological fluids or tissues may aid in disease diagnosis,
monitoring disease progression, and predicting treatment responses in patients with
neurological disorders, cancer, or metabolic disorders.
Immunotherapy: Gangliosides, particularly GD2 and GD3, are attractive targets for
immunotherapy in cancer treatment. Monoclonal antibodies targeting gangliosides on
tumor cells, such as anti-GD2 antibody in neuroblastoma, have shown efficacy in
clinical trials and are being explored as therapeutic agents in other cancer types.

Prostaglandin Structure
Prostaglandins, a class of bioactive lipid compounds, possess a unique and intricate
molecular structure that underlies their diverse physiological functions. Understanding
the fundamental components of this structure is crucial for appreciating their roles in
human biology.

The Central Five-Membered Ring:

At the core of every prostaglandin molecule lies a distinctive twenty-carbon skeleton,
featuring a central five-membered ring. This ring contains oxygen atoms at specific
positions, imparting reactivity and distinct chemical properties to prostaglandins. It is
this ring that differentiates prostaglandins from other lipid compounds and serves as
the foundation for their classification into various types.

Hydrophobic Hydrocarbon Chains:

Surrounding the central ring structure are two long hydrophobic hydrocarbon chains,
often referred to as "side chains." These chains vary among different prostaglandin
types, influencing the molecule's overall size, shape, and biological activities.

- Chain Length: Prostaglandins can have shorter or longer hydrocarbon chains. The
length of these chains affects the molecule's size and shape, influencing its
interactions with cellular receptors and other biomolecules.

- Degree of Unsaturation: Some prostaglandins contain double bonds within their

hydrocarbon chains, introducing kinks and flexibility into the molecule's structure. The
presence and position of these double bonds impact the prostaglandin's stability and
reactivity.

- Functional Groups: Certain prostaglandins have unique functional groups attached to

their hydrocarbon chains. These functional groups, such as hydroxyl (-OH), keto (=O),
and carboxyl (-COOH) groups, contribute specific chemical properties to the
prostaglandin, making it suitable for particular physiological functions.

Classification by Series:
Prostaglandins are further categorized into different series, often denoted by letters
(e.g., PGE, PGF, PGI). Each series encompasses multiple subtypes of prostaglandins,
each with its unique set of side chains. This classification system helps organize and
categorize the diverse prostaglandin molecules, simplifying the understanding of their
functions and roles within the body.

Types of Prostaglandins
Prostaglandins exhibit an astounding array of functions within the human body, with
various types performing distinct roles:

PGE2 (Prostaglandin E2): PGE2 is a key player in the inflammatory response, pain
perception, and the regulation of body temperature. Its involvement in the immune
response has led to its designation as a target for anti-inflammatory drugs, including
nonsteroidal anti-inflammatory drugs (NSAIDs).

PGF2α (Prostaglandin F2α): PGF2α is notable for its influence on smooth muscle
contraction. This prostaglandin is crucial in processes such as uterine contractions
during childbirth and the regulation of intraocular pressure.

PGI2 (Prostacyclin): Prostacyclin stands out as a potent vasodilator and inhibitor of

platelet aggregation. It plays a vital role in maintaining the integrity of blood vessels
and preventing clot formation.

TXA2 (Thromboxane A2): Thromboxane A2 plays a central role in promoting platelet

aggregation and vasoconstriction. This function is pivotal in clot formation and
hemostasis.
 Prostaglandin
synthesis pathway (Resler et al., 2014).

Prostacyclin vs. Prostaglandin: Understanding the

Distinctions
Prostacyclin (PGI2) and prostaglandins are both members of the prostanoid family, a
subgroup of eicosanoids derived from arachidonic acid. While they share some
common structural elements and biosynthetic pathways, they exhibit significant
differences in terms of their biological roles and effects within the body.

Prostacyclin (PGI2):
Vasodilation: Prostacyclin is primarily recognized for its potent vasodilatory effects. It
relaxes and widens blood vessels, leading to a decrease in blood pressure. This
vasodilation is crucial for regulating blood flow and maintaining vascular health.

Antiplatelet Activity: One of the most essential functions of prostacyclin is its role as an
inhibitor of platelet aggregation. It prevents blood platelets from sticking together and
forming clots within blood vessels. This antiplatelet activity is vital for preventing
unwanted clot formation and maintaining blood vessel integrity

Endothelial Production: Prostacyclin is primarily produced by the endothelial cells

lining the blood vessels. It acts as a local signaling molecule, exerting its effects near
the site of production.

Cardiovascular Protection: Due to its vasodilatory and antiplatelet properties,

prostacyclin plays a critical role in protecting the cardiovascular system. It helps
prevent conditions like thrombosis, atherosclerosis, and hypertension.

Prostaglandins:
Inflammatory Mediators: Prostaglandins, in contrast, are known for their roles in
inflammation and immune responses. They are produced at sites of injury or infection
and promote inflammation, leading to increased blood flow and immune cell
recruitment to the affected area.

Fever Regulation: Some prostaglandins, particularly PGE2, contribute to fever by

acting on the hypothalamus, raising the body's temperature setpoint.
 Pain Perception: Prostaglandins also sensitize pain receptors, making tissues more
sensitive to pain. This property is why they are often targeted by pain-relief
medications like nonsteroidal anti-inflammatory drugs (NSAIDs).

Diverse Functions: Beyond inflammation, prostaglandins have diverse functions,

including regulating uterine contractions during childbirth (PGF2α), influencing smooth
muscle contraction (e.g., bronchoconstriction, gastrointestinal motility), and modulating
gastric acid secretion.

Cholesterol, a vital lipid with a 4-ring steroid structure, is crucial for cell membrane
structure and fluidity, acts as a precursor for steroid
hormones (like estrogen, testosterone, and cortisol), bile acids, and Vitamin D, and
plays roles in cell signaling and intracellular transport. Its metabolism involves
absorption from food, synthesis in the liver from acetyl-CoA, transport via
lipoproteins (like LDL and HDL), conversion to bile acids or hormones, and reverse
transport back to the liver for processing or excretion.
Structure of Cholesterol

• Cholesterol is a 27-carbon
steroid alcohol.
• Its structure features a rigid, four-ring sterol nucleus, a short hydrocarbon tail, and a
hydroxyl group.
• This structure makes it a non-polar lipid, requiring packaging with proteins
into lipoprotein particles for transport in the blood.
Functions of Cholesterol
• Cell Membrane Structure:
It is an essential component of cell membranes, providing stability and regulating
fluidity over various temperatures.
• Steroid Hormone Synthesis:
Cholesterol is the fundamental precursor for all steroid hormones, including sex
hormones (estrogen, testosterone), corticosteroids (cortisol), and
mineralocorticoids.
• Bile Acid Production:
The liver uses cholesterol to synthesize bile acids, which are essential for the
digestion and absorption of fats and fat-soluble vitamins in the intestine.
• Vitamin D Synthesis:
In the skin, cholesterol is converted into a precursor that, with UV radiation,
becomes Vitamin D.
• Cell Signaling and Transport:
Cholesterol is involved in intracellular transport, cell signaling, and the structure of
specialized membrane domains like caveolae.
 Metabolism of Cholesterol
• Synthesis:
Cholesterol is synthesized in the liver from acetyl-CoA through a pathway called
the mevalonate pathway.
• Transport:

Dietary cholesterol and newly synthesized cholesterol are packaged into lipoprotein
particles for transport in the circulation.
• LDL: Primarily transports cholesterol from the liver to peripheral tissues.
• HDL: Transports excess cholesterol from peripheral tissues back to the
liver (reverse cholesterol transport) for excretion or reuse.
• Storage:
Excess cholesterol is often converted into cholesteryl esters and stored within
cells.
• Excretion:
The liver secretes cholesterol into the bile, where some is excreted in feces.
• Regulation:
The entire process of cholesterol synthesis, absorption, transport, and utilization is
tightly regulated to maintain homeostasis and prevent abnormal deposition,
particularly in arteries, which can lead to atherosclerosis.

Cholesterol metabolism
What Is Cholesterol and How Does It Work?
Cholesterol, a type of lipid, is widely found in various tissues of the body. Human gets
cholesterol through dietary intake and the body's biosynthesis. Animal sources of egg yolks,
meat, and cream are important sources for cholesterol. And cholesterol is mainly synthesized
in the liver and intestinal mucous membranes. Cholesterol is a basic component of plasma
membranes, and it also can make steroid hormone, vitamin D and bile acids that help digest
lipids. Therefore, most tissues need to maintain the right cholesterol supply to keep the
metabolic balance of cholesterol.
What Is Cholesterol Metabolism?
Cholesterol metabolism refers to a series of biochemical reactions that occur when
cholesterol is synthesized and broken down in the body.
The Function of Cholesterol Metabolism
Normal cholesterol metabolism keeps cholesterol levels in balance, ensuring the survival and
normal functioning of the organism.
How Is Cholesterol Metabolized?
Anabolism of Cholesterol:
Cholesterol in the human body mainly comes from endogenous biosynthesis. Cholesterol is
primarily synthesized in the endoplasmic reticulum (liver) from acetyl-CoA, one of the
metabolites of glucose, fatty acids, and certain amino acids. Endogenous synthetic cholesterol
starts from a series of enzymatic reactions in which acetyl-CoA is mediated by HMG-CoA
reductase (HMGCR), squalene synthase, squalene monooxygenase, lanosterol synthase,
and farnesyl-diphosphate synthase (FPPS).
The cholesterol synthesis pathway is a multi-stage process.
First, two molecules of acetyl-CoA are catalyzed to one molecule of acetoacetyl-CoA by
thiolase.
Acetyl-CoA and acetoacetyl-CoA forms HMG-CoA in the action of HMG-CoA synthetase.
The HMG-CoA reductase catalyzes HMG-CoA to generate mevalonic acid (MVA). The process
is irreversible. HMG reductase is a rate-limiting enzyme for cholesterol synthesis.
Upon phosphorylation, decarboxylation, and dehydroxylation, MVA is condensed to form
squalene.
Squalene produces lanosterol through the catalysis of endoplasmic reticulum cyclase and
oxygenase.
Finally, lanosterol is converted to cholesterol through multiple redox reactions.
In addition to the body's synthesis, cholesterol can also be absorbed from the small intestine.
The main sources of cholesterol in the intestine are food, bile and shed intestinal epithelial
cells. Triglycerides and phospholipids are gradually broken down and digested after the
lipids in food are processed by various digestive enzymes in the small intestine, releasing free
cholesterol. There is also a large amount of free cholesterol in the bile, which is excreted into
the bile by sterol transporter ABCG5 or ABCG8 on the liver membrane. In humans, NPC1L1
(Niemann-pick type C1 like 1), a transmembrane protein, is also expressed on the bile duct
membrane and is responsible for re-absorbing cholesterol secreted into bile by the liver.
Catabolism of Cholesterol:
The catabolism of cholesterol is also mainly carried out in the liver. Cholesterol cannot be
completely oxidized and decomposed into CO2 and H2O in the body. It is transformed into
other compounds containing cyclopentane poly-hydro phenanthrene parent nuclei through
oxidation and reduction. And these compounds continue to enter the metabolism process in
vivo or are expelled from the body.
Cholesterol is an important component of the cell membrane in the body. Besides, it can also
be converted into a variety of substances with important physiological functions. For
example, cholesterol can be converted into adrenal cortical hormones and sex hormones such
as androgen, estrogen, and progesterone. In the skin, cholesterol can be oxidized to 7-
dehydrogenated cholesterol, which is often converted to vitamin D3 by ultraviolet radiation.
In the liver, cholesterol can be oxidized into bile acids. And then bile acids flow into the
duodenum where they promote the digestion of lipids and the absorption of lipid-soluble
vitamins.
In addition to the body's conversion and use of cholesterol, some excess cholesterol is
catalyzed to form the cholesterol ester by acetylcholesterol transferase (ACAT) and then
stored in the cell. Cholesterol ester transport was mainly mediated by ABCA1 (ATP-binding
cassette sub-family A) and ABCG1 (ATP-binding cassette sub-family G member1). Some other
cholesterol is directly excreted into the intestinal cavity. And partial cholesterol is assembled
as high-density lipoprotein, which later enters to the liver for catabolism. In the lower part of
the small intestine, most bile acids are reabsorbed into the liver through the hepatic
circulation. The process contributes to the hepatointestinal circulation of bile. A small
amount of bile acid is excreted by intestinal bacteria. Besides, the liver can also drain
cholesterol directly into the intestine. Cholesterol can also be reduced to sterol fecal by
intestinal bacteria. The sterol fecal subsequently is transported out of the body.
Intracellular Transport of Cholesterol
The transport of cholesterol involves both the transport of endogenous cholesterol from the
liver to the tissues of the body for use and the transport of cholesterol back to the liver for
catabolism.
Cholesterol is transported in the blood as a lipoprotein. Cholesterol combines with
apolipoprotein in the blood to form various forms of lipoprotein, such as chylomicron, very-
low-density lipoprotein (VLDL), low-density lipoprotein (VLIDL), and high-density
lipoprotein (HDL). LDL is mediated by the LDLR into cells. HDL is mediated by scavenger
receptor (SR-B1). SR-B1 is related to cholesterol entering and leaving cells and plays an
important role in the main signaling pathway of human steroid-producing cells.
Chylomicron: It is responsible for the transport of triglycerides, phospholipids, and
cholesterol absorbed by the intestine.
High-density lipoprotein (HDL): It is also known as "good" cholesterol because it mainly
transfers cholesterol from tissues other than the liver to the liver for catabolism. Many
studies have shown that HDL is a unique type of lipoprotein that "sucks" cholesterol out of
the walls of atherosclerotic blood vessels and transports it to the liver for metabolic
clearance. Therefore, HDL is honored as"anti-atherosclerotic lipoprotein".
Low-density lipoprotein (LDL): Cholesterol is mainly transported in the blood as LDL-c.
LDL transfers cholesterol from the liver to other tissues in the body. Oxidized LDL is one of
the risk factors for atherosclerosis. High-level LDL can cause plaque to build up in arteries, so
LDL is "bad" cholesterol.
Very-low-density lipoprotein (VLDL): Some people also call VLDL "bad" cholesterol
because it causes plaque to accumulates in arteries too. Differently, VLDL carries
triglycerides, LDL transports cholesterol.
The Regulation of Cholesterol Metabolism
The main way to maintain the balance of intracellular cholesterol metabolism is a negative
feedback regulation of cholesterol synthesis, including transcription level and protein level.
Transcription level refers to the regulation of the genes expression of cholesterol synthesis
by the SCAP-SREBP pathway in the endoplasmic reticulum. The protein level is the
degradation of cholesterol by HMG-CoA reductase (HMGCR).
When intracellular cholesterol level is high, the sterol sensing structure domain (SSD) of
SCAP (SREBP cleavage-activating protein) perceives endoplasmic reticulum cholesterol
levels and combines with Insig, which causes SREBP/SCAP complexes to be stranded in the
endoplasmic reticulum. And then, it inhibits the expression of cholesterol synthesis genes
such as HMGCR. On the other hand, lanosterol, the intermediate of cholesterol synthesis, can
promote the degradation of HMGCR, thus reducing the synthesis of cholesterol. Cholesterol
also can repress the activity of HMGCoA reductase and reduce the synthesis of this enzyme,
thereby reducing the synthesis of cholesterol.
When the cholesterol level lows in the cell, SCAP protein conformation changes, and then
separates from Insig and assists the SREBP precursor transport from the endoplasmic
reticulum to the Golgi apparatus. The SREBP precursor is spliced by S1P (Site-1
protease), existed on the Golgi apparatus, producing nSREBPs with transcriptional activity.
nSREBPs transit into the nucleus and activate the expression of downstream related genes of
cholesterol synthesis approach by combining sterol regulatory elements, such as LDLR and
HMGCR. The increase of LDLR on the cell membrane surface can promote the transport of
LDL from plasma to intracellular, thus increasing the level of intracellular cholesterol and
reducing the content of plasma LDL. And the increase of HMGCR can facilitate the
biosynthesis of cholesterol. This is how cells maintain the homeostasis of cholesterol levels.
Diseases and Cholesterol Metabolism
Cholesterol plays important and multiple physiological roles in cells and is an indispensable
component of cell life activities. Therefore, cholesterol must be strictly and precisely
regulated to ensure its stable intracellular content. However, the cholesterol level within cells
is affected by the dysfunction of cholesterol synthesis, abnormal transportation, and
disorganized absorption or excretion, etc. All these factors could lead to various diseases
related to abnormal cholesterol metabolism.
Cholesterol is mainly transported in the blood as LDL-C. Macrophages take up excessive LDL
lipoprotein particles accumulated on the blood vessel wall. And then HDL transports the
cholesterol into the liver for catabolization. When the LDL level is too high to exceed the
transport capacity of HDL, the macrophages in the blood vessels will intake large amounts of
lipids to form foam cells. Large amounts of foam cells build up in the arterial endothelium to
form an uneven distribution of plaque, causing atherosclerosis.
Studies have demonstrated that Huntington's disease is linked to cholesterol metabolism in
the brain. By increasing the expression of cholesterol 24-hydroxylase in the brains of
Huntington's mice, the mice's neurons shrank, Huntington protein aggregates decreased, and
their exercise improved. It also suggests that restoring normal metabolism of cholesterol in
the brains of Huntington's patients could be a potential treatment for the disease.
High cholesterol could cause hyperlipidemia, heart attacks, and strokes. If the cholesterol
level is too low, many physiological functions cannot be performed normally. So the people
will be prone to certain diseases and have a higher prognostic risk of death. Cholesterol
metabolism disorder is one of the risk factors of coronary heart disease, Alzheimer's disease,
obesity, diabetes, etc.

Fatty Acid Biosynthesis

• Lipid, considered a principal form of stored energy, phospholipid is the
significant component of the Plasma Membrane.

• The liver, Kidney, adipose tissue, and lactating mammary glands are the
organs where the de-novo synthesis of fatty acids occurs.

• The site for Fatty acid biosynthesis is cytosol.

1.0Introduction of Fatty Acid Biosynthesis of Fats

The synthesis of fatty acids starting from a simple precursor (acetyl CoA) is
known as de- novo lipogenesis. In animals (and yeast), it occurs primarily in the
cytosol of various tissues such as the liver, adipose (fat) tissue, central nervous
system and lactating mammary glands. In plants, the enzymes are present in
chloroplasts. Lipogenesis is an endergonic reductive process. The source of the
reductant is NADPH. The fatty acid synthesis intermediates are covalently
linked to an acyl carrier protein.

2.0Fatty Acid Synthase Enzyme

Fatty Acid Synthase complex is a multifunctional enzyme which is made up of
dimers with two identical subunits, including ACP (Acyl Carrier Protein). ACP
is responsible for transferring the acyl group from acetyl CoA and 2 carbon
fragments from malonyl CoA to elongate the carbon chain required for fatty
acid biosynthesis, such as 16 carbon compounds called Palmitate. Fatty acid
synthase complex is made up of -

• Acetyl transacylase

• Malonyl transacylase

• Ketoacyl synthase
 • Ketoacyl reductase

• Dehydratase

• Enoyl reductase

• Thioesterase

3.0Steps Involved in Fatty Acid Synthesis

Production of Acetyl CoA and NADPH

Acetyl CoA is produced in mitochondria by oxidation of pyruvate (PDH

complex) and fatty acid oxidation. Oxidation of Palmitic acid (fatty acid) gives
8 molecules of acetyl CoA. However, the problem is that acetyl CoA cannot
permeate mitochondria as it has to go to the cytosol for FAB. So, in
mitochondria, acetyl CoA condenses with OAA to form citrate. Citrate can pass
through the mitochondrial membrane and enter the cytosol, where an enzyme
called citrate lyase cleaves citrate into OAA and Acetyl CoA. OAA is converted
into malate in cytosol and malate into pyruvate by malic enzyme with NADPH
formation, a reducing equivalent required for fatty acid biosynthesis.

Citrate + ATP + HSCo + H2O → AcetylCoA + ADP + Pi + OAA

Formation of malonyl CoA

It is formed by the carboxylation of acetyl CoA by an enzyme called acetyl CoA

carboxylase. This enzyme is ATP-dependent and requires biotin as a cofactor.
Reactions are catalyzed by the Fatty Acid Synthase complex to form long-chain
fatty acid called Palmitic acid/Palmitate

The acyl group from acetyl CoA and the malonyl group from malonyl CoA are
transferred to fatty acid synthase complex by Acetyl CoA-ACP transacylase and
Malonyl CoA-ACP transacylase.

Step 1 . Condensation Reaction

Acyl (from acetyl CoA) is the first acyl group, and 2 carbons derived from
malonyl extend the acyl chain by 2 carbons. This condensation of both
molecules is associated with decarboxylation, and the product form is 𝛃- keto
butyryl-ACP. The enzyme is 𝛃- ketoacyl-ACP synthase.
Step 2 . Reduction Reaction

𝛃- keto butyryl-ACP is then undergoing reduction, and the ketoacyl group is

turned into the hydroxyl group. The electron donor is NADPH. The enzyme is
𝛃- ketoacyl-ACP reductase. The final product is 𝛃- hydroxybutyryl-ACP

Step 3 . Dehydration reaction

𝛃- hydroxybutyryl ACP undergoes dehydration and forms enoyl ACP. The

enzyme is Beta hydroxyacyl-ACP dehydratase. Water is eliminated during the
dehydration reaction, and the product formed is butenoyl-ACP.

Step 4. Reduction reaction

Enoyl ACP reductase catalyzes this reaction using NADPH as a reducing

equivalent and forms Acyl ACP.

The 4-carbon unit attached to ACP is butyryl. ACP is the carrier molecule that
transfers the carbon chain to the cysteine part of the fatty acid synthase enzyme
complex, and in this way, the reactions mentioned above are repeated 6 more
times. Note: A total of 7 reactions were repeated to form 16 carbon palmitate
molecules. Each time, the chain is elongated by 2 carbon units. Then, finally,
palmitoyl thioesterase separates Palmitate from ACP. In this way, a fully
saturated 16-carbon compound is called Palmitate and is formed.

4.0Synthesis of Long Chain Fatty Acids

 • Elongation by the fatty acid synthase complex stops after formation of
Palmitate (16 C).

• Other enzyme systems carry out further elongation and the formation
of double bonds.

• The major product of fatty acid biosynthesis is the 16-carbon Palmitate.

Additional enzymes are required to synthesize longer-chain fatty acids.

• Chain elongation reactions occur both in mitochondria and in

microsomes.

• Microsomes are small membrane-enclosed vesicles derived from the

endoplasmic reticulum of cells.

• Mitochondria and microsomes carry out chain elongation by adding

two-carbon units to fatty acids.

• The microsomal system is highly physiologically important because it

provides the long-chain fatty acids (18-24C) required for the
myelination of nerve cells in animals.

• Chain elongation occurs through a condensation, reduction, and

dehydration cycle, followed by another reduction that parallels
cytosolic fatty acid biosynthesis.

• The more active elongation system adds two carbons to palmitoyl-CoA

to make it steroyl CoA.

• The elongation mechanism is identical to that used to synthesize

Palmitate, except for the enzyme systems and the acyl carrier protein.

5.0Biosynthesis of Unsaturated Fatty Acids

• There are two pathways for synthesizing unsaturated fatty acids:
aerobic and anaerobic.

• The aerobic pathway is almost universal, but the anaerobic pathway is

rare, and the two pathways have not been reported from the same
organism.

• Most monounsaturated fatty acids (palmitoleic and oleic acid) produced

have a ∆-9 double bond.

• The aerobic pathway is mediated by a desaturase complex with three

proteins: a flavoprotein (NADH-cytochrome b5 reductase), cytochrome
b5, and the desaturase present in the SER of animal cells. The
desaturases belong to mixed-function oxidases as both fatty acid and
NADPH (co-substrate) are simultaneously oxidized. Various
 unsaturated fatty acids can be formed from oleate by combining
elongation and desaturation reactions.

• In most cases, the double bonds introduced are in the cis configuration.
Eukaryotes ' polyunsaturated fatty acids (PUFA) generally have
unconjugated (interrupted by a methylene group) double bonds.

• Although plants and animals synthesize several long-chain unsaturated

fatty acids, the difference arises due to the specific desaturases each one
expresses.

• Both produce ∆-9 desaturases; animal desaturases introduce

subsequent double bonds between C-9 and the carboxyl group, whereas
plants introduce additional double bonds between C-9 and the methyl
group (omega end). Some mammalian desaturases include ∆-6, ∆-5 and
∆-4, while plants have ∆-12 and ∆-15 desaturases. Most bacteria lack
polyunsaturated fatty acids.

6.0Regulation of Fatty Acid Synthesis

• Hormones, enzymes, metabolites and end products control it.

• Acetyl CoA carboxylase: This enzyme is active in polymeric form and

inactive in monomeric form. Citrate promotes its polymeric form,
whereas palmitoyl CoA and malonyl CoA promote its inactivation.
 • Hormonal control includes cAMP-dependent phosphorylation for
inactivation and vice versa for activation. Insulin promotes fatty acid
synthesis, and glucagon inhibits it.

• Availability of NADPH—It is provided by citrate (Acetyl CoA) or

PPP/HMS (Hexose monophosphate shunt pathway), which significantly
influences Fatty acid synthesis.

Beta Oxidation of Fatty Acid: Steps, Uses,

Diagram
Beta-oxidation is the catabolic process by which fatty acid molecules are
broken down in the cytosol in prokaryotes and in the mitochondria in
eukaryotes to generate acetyl-CoA. Acetyl-CoA enters the citric acid
cycle while NADH and FADH2, which are co-enzymes, are used in the electron
transport chain. It is referred as “beta oxidation” because the beta carbon of
the fatty acid undergoes oxidation to a carbonyl group.

Beta-oxidation of Fatty Acid

A key metabolic process that breaks down fatty acids and produces ATP
and other compounds rich in energy is beta-oxidation. This activity takes
place in cells’ mitochondria and is crucial for maintaining energy balance,
especially during fasting or vigorous exercise. We shall investigate the
mechanism, control, and relevance of beta-oxidation in this article, focusing
on its role in energy generation and metabolic diseases. The majority of the
molecules that make up the human body’s stores of energy are fatty acids.
They are typically produced in the liver from dietary fats. Long hydrocarbon
chains with a carboxyl group at one end make up fatty acids.
They can have one or more double bonds or be saturated (no double
bonds). A large energy reserve known as adipose tissue contains
triglycerides, which are fatty acids. The triglycerides that have been stored
are converted into fatty acids and glycerol when energy demands rise, such
 as during fasting or physical activity. Energy generation depends on the
following breakdown of fatty acids via beta-oxidation.

Mechanism of Beta-oxidation of Fatty Acid

Beta-oxidation of fatty acids occurs in several stages, with each stage taking
place in specific tissues within the body. Let’s explore the stages and tissues
involved in the beta-oxidation process.

Stage 1: Activation and Transport of Fatty Acids

The first stage of beta-oxidation involves the activation and transport of
fatty acids. This step occurs in the cytoplasm of cells.
1. Activation
• Fatty acids, whether derived from dietary intake or adipose tissue
mobilization, undergo activation before entering the mitochondria.
• In this process, fatty acyl-CoA synthetase enzymes activate fatty acids by
coupling them with coenzyme A (CoA).
• This reaction requires the hydrolysis of ATP, resulting in the formation of
fatty acyl-CoA molecules.
2. Transport
• The activated fatty acyl-CoA molecules are transported across the
mitochondrial membrane to enter the mitochondrial matrix, where beta-
oxidation takes place.
• This transport is facilitated by a specific transport protein called carnitine
palmitoyltransferase I (CPT-I), located in the outer mitochondrial
membrane.
• CPT-I catalyzes the exchange of CoA with carnitine, allowing the fatty
acyl-carnitine to traverse the mitochondrial membrane.
• Once inside the mitochondrial matrix, another enzyme, carnitine
palmitoyltransferase II (CPT-II), converts the fatty acyl-carnitine back into
fatty acyl-CoA, ready for beta-oxidation.
Stage 2: Beta-Oxidation Cycle
The second stage involves the actual beta-oxidation cycle, where fatty acids
undergo a series of reactions to generate acetyl-CoA units. This stage
occurs within the mitochondrial matrix.
1. Oxidation: The fatty acyl-CoA undergoes a series of oxidation reactions,
resulting in the removal of two carbon atoms in the form of acetyl-CoA. The
first step involves the oxidation of the fatty acyl-CoA by acyl-CoA
dehydrogenase, which introduces a double bond between the alpha and
beta carbons of the fatty acid chain. This generates trans-enoyl-CoA.
2. Hydration: The trans-enoyl-CoA molecule undergoes hydration catalyzed
by enoyl-CoA hydratase, also known as crotonase. This step adds a water
molecule across the double bond, resulting in the formation of L-3-
hydroxyacyl-CoA.
3. Dehydrogenation: The L-3-hydroxyacyl-CoA is further oxidized by L-3-
hydroxyacyl-CoA dehydrogenase, generating 3-ketoacyl-CoA. This step
involves the transfer of electrons to NAD+, producing NADH.
4. Thiolytic Cleavage: The final step of the beta-oxidation cycle involves the
cleavage of the 3-ketoacyl-CoA by beta-keto thiolase. This cleavage
generates acetyl-CoA and a shorter fatty acyl-CoA chain, which is two
carbons shorter than the original fatty acid. The shorter fatty acyl-CoA then
re-enters the beta-oxidation cycle, repeating the series of reactions until
the entire fatty acid is oxidized.
Stage 3: Generation of ATP and Metabolic
Intermediates
• The acetyl-CoA molecules generated through beta-oxidation can enter
the citric acid cycle (also known as the Krebs cycle or TCA cycle) to
produce ATP through oxidative phosphorylation.
• This stage occurs in the mitochondrial matrix. The acetyl-CoA molecules
derived from beta-oxidation enter the citric acid cycle, where they
undergo a series of reactions, producing reducing equivalents (NADH and
FADH2) and GTP (which can be converted to ATP).
• These reducing equivalents are utilized in the electron transport chain to
generate ATP through oxidative phosphorylation.
Tissues Involved in Beta-Oxidation
 Beta-oxidation occurs in various tissues within the body, depending on the
specific energy demands and metabolic states.
1. Liver: The liver is a significant site of fatty acid oxidation, particularly
during fasting. It plays a crucial role in mobilizing fatty acids from stored
triglycerides in response to energy needs and producing ketone bodies as
an alternative fuel source.
2. Skeletal Muscle: Skeletal muscle is another important tissue for beta-
oxidation. During periods of exercise or increased energy demands, skeletal
muscle utilizes fatty acids as a source of fuel for ATP production.
3. Adipose Tissue: Adipose tissue primarily functions as a storage site for
triglycerides. However, during energy deficit or fasting, adipose tissue
releases stored fatty acids through lipolysis, which can be taken up and
oxidized by other tissues for energy production.
4. Cardiac Muscle: The heart relies heavily on fatty acid oxidation for energy
production, as it has a high energy demand. Beta-oxidation provides a
significant portion of ATP to support the continuous contraction and
relaxation of the cardiac muscle.
Beta-oxidation of fatty acids occurs in multiple stages, starting with the
activation and transport of fatty acids, followed by the beta-oxidation cycle
within the mitochondria. This process generates acetyl-CoA units, which can
be further metabolized in the citric acid cycle to produce ATP. Different
tissues, including the liver, skeletal muscle, adipose tissue, and cardiac
muscle, contribute to the overall beta-oxidation process, depending on
energy demands and metabolic requirements.

Transport of Acyl-CoA into Mitochondria

The transport of acyl-CoA molecules into the mitochondria for beta-
oxidation involves a specialized system known as the carnitine shuttle. This
shuttle ensures the efficient entry of fatty acids into the mitochondrial
matrix, where beta-oxidation takes place. The process of acyl-CoA transport
involves several key steps:
1. Activation of Fatty Acids
• Before fatty acids can be transported into the mitochondria, they need to
be activated to form fatty acyl-CoA.
• This activation occurs in the cytoplasm of cells and is catalyzed by
enzymes called fatty acyl-CoA synthetases.
• Fatty acyl-CoA synthetases activate fatty acids by coupling them with
coenzyme A (CoA), forming fatty acyl-CoA molecules.
2. Formation of Acylcarnitine
• Once the fatty acids are activated to form fatty acyl-CoA, they cannot
directly cross the mitochondrial inner membrane due to its
impermeability to these large molecules.
• Instead, the fatty acyl-CoA is converted into acylcarnitine through a
reaction catalyzed by the enzyme carnitine palmitoyltransferase I (CPT-I).
 CPT-I is located on the outer mitochondrial membrane and facilitates the
transfer of the acyl group from CoA to carnitine, forming acylcarnitine.
• This reaction is accompanied by the release of free CoA.
3. Transport of Acylcarnitine:
• Acylcarnitine, being a smaller molecule, can readily cross the
mitochondrial inner membrane through a carnitine-acylcarnitine
translocase (CACT).
• CACT transports acylcarnitine into the mitochondrial matrix while
simultaneously transporting free carnitine out of the matrix and back to
the cytoplasm.
• This exchange ensures a continuous supply of carnitine for the CPT-I-
mediated formation of acylcarnitine.
4. Regeneration of Acyl-CoA:
• Once inside the mitochondrial matrix, the acylcarnitine is converted back
into acyl-CoA through a reaction catalyzed by the enzyme carnitine
palmitoyltransferase II (CPT-II).
• CPT-II is located on the inner mitochondrial membrane and facilitates the
transfer of the acyl group from carnitine back to CoA, regenerating acyl-
CoA.
• The released carnitine is then transported back to the cytoplasm to
participate in subsequent rounds of fatty acid transport.
The transport of acyl-CoA into the mitochondria via the carnitine shuttle is
a crucial step in facilitating beta-oxidation. It ensures that fatty acids are
efficiently delivered to the site of beta-oxidation, allowing for the
generation of ATP and metabolic intermediates. The regulation of this
transport system, particularly the activity of CPT-I, is tightly controlled by
various factors, including hormonal signals and the metabolic state of the
cell. These regulatory mechanisms ensure a balanced utilization of fatty
acids and maintain energy homeostasis in the body.

Regulation of Beta-Oxidation
• The management of beta-oxidation is complex and involves a number of
elements that guarantee optimal energy storage and use.
• During periods of high energy demand, hormones like glucagon and
adrenaline enhance beta-oxidation, but insulin suppresses it during the
fed state.
• Long-chain fatty acyl-CoA molecules are transported into the
mitochondria by the necessary molecule carnitine.
• The rate of beta-oxidation is determined by its availability. The rate-
limiting enzyme that regulates the entrance of fatty acids into the
mitochondria is carnitine palmitoyltransferase I (CPT-I).
• The proportion of malonyl-CoA to carnitine controls CPT-I. Malonyl-CoA
levels rise when energy storage rises, blocking CPT-I and decreasing the
transport of fatty acids into the mitochondria.
• On the other hand, malonyl-CoA levels fall after fasting or exercise, raising
CPT-I activity and boosting beta-oxidation.
• The regulation of beta-oxidation is also influenced by the availability of
cofactors and substrates.
• For instance, the activity of enzymes involved in beta-oxidation is
dependent on the presence of NAD+, FAD, and CoA.
• Adequate levels of these cofactors ensure the efficient functioning of the
pathway.
Role of Fatty Acids in Regulation of Beta-
Oxidation
The supply of fatty acids plays a significant role in regulating fatty acid
beta-oxidation. The availability of fatty acids for oxidation depends on
various factors, including dietary intake, adipose tissue mobilization, and de
novo lipogenesis. The regulation of fatty acid supply ensures the
appropriate balance between energy utilization and storage in the body.

1. Dietary Intake
• The consumption of dietary fats provides a source of exogenous fatty
acids for beta-oxidation.
• The composition of the diet, particularly the types of fatty acids
consumed, can influence the regulation of beta-oxidation.
• Saturated fatty acids, which lack double bonds, are more easily
metabolized compared to unsaturated fatty acids with one or more
double bonds.
• Additionally, the length of the fatty acid chain affects its oxidation rate,
with shorter-chain fatty acids being oxidized more readily.
2. Adipose Tissue Mobilization
• During periods of energy deficit or fasting, adipose tissue serves as a
crucial reservoir of stored triglycerides.
• Hormonal signals, such as glucagon and adrenaline, stimulate the
mobilization of fatty acids from adipose tissue through lipolysis.
• Hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) are key
enzymes involved in the breakdown of triglycerides into fatty acids and
glycerol.
• The released fatty acids can then be taken up by peripheral tissues,
including muscle and liver, for beta-oxidation.
3. De Novo Lipogenesis
• In addition to dietary intake and adipose tissue mobilization, the de novo
synthesis of fatty acids, known as de novo lipogenesis (DNL), can also
influence the supply of fatty acids for beta-oxidation.
• DNL primarily occurs in the liver and is regulated by nutritional and
hormonal factors.
• When dietary carbohydrate intake is high, excess glucose is converted
into acetyl-CoA, which serves as a precursor for fatty acid synthesis.
• Under conditions of energy surplus, DNL can contribute to an increase in
fatty acid supply for storage or oxidation, depending on the metabolic
needs of the body.
• The supply of fatty acids for beta-oxidation is tightly regulated to ensure
metabolic efficiency and energy homeostasis.
• Several factors influence this regulation, including hormonal signals and
metabolic intermediates.
1. Hormonal Regulation
• Hormones such as insulin, glucagon, and adrenaline play crucial roles in
regulating fatty acid supply and beta-oxidation.
• Insulin, released in response to high blood glucose levels, promotes
glucose uptake and utilization, inhibiting lipolysis and fatty acid release
from adipose tissue.
• In contrast, glucagon and adrenaline, released during fasting or exercise,
stimulate lipolysis and increase the availability of fatty acids for oxidation.
2. Metabolic Intermediates
• Metabolic intermediates within the beta-oxidation pathway can feedback
and regulate the supply of fatty acids.
• For instance, malonyl-CoA, an intermediate in fatty acid synthesis, inhibits
the entry of fatty acids into mitochondria for beta-oxidation.
• This ensures that fatty acids are channeled toward storage when energy
needs are met.
• Conversely, during conditions of energy deficit, malonyl-CoA levels
decrease, relieving this inhibition and promoting the transport of fatty
acids into the mitochondria for oxidation.
The regulation of fatty acid supply is essential for maintaining energy
balance and metabolic flexibility. Dysregulation in this process can
contribute to metabolic disorders such as obesity, insulin resistance, and
fatty acid oxidation disorders. Understanding the intricate mechanisms that
control the supply of fatty acids and their integration with beta-oxidation
provides insights into the pathophysiology of metabolic diseases and can
help develop targeted therapeutic strategies.

Significance of Beta-Oxidation
• The body’s ability to produce energy and maintain its energy balance
depends heavily on beta-oxidation.
• When glucose levels are low by prolonged fasting or strenuous activity
and fatty acids are the body’s main fuel source, this is very crucial.
• Acetyl-CoA, which may join the citric acid cycle and create the reducing
equivalents (NADH and FADH2), is produced by the beta-oxidation of
fatty acids.
• The electron transport chain uses these reducing equivalents after that to
produce ATP by oxidative phosphorylation.
• Therefore, beta-oxidation makes a considerable contribution to ATP
synthesis and the body’s overall energy balance.
• Additionally, beta-oxidation plays a role in a number of metabolic
diseases.
• Fatty acid oxidation disorders (FAODs), a group of metabolic illnesses, can be
caused by flaws in the beta-oxidation-related enzymes.
• Inefficient fatty acid breakdown causes a buildup of fatty acyl-CoA
intermediates, which is a hallmark of several illnesses.
• Severe metabolic crises, such as hypoglycemia, liver failure, muscular weakness,
and cardiomyopathy, can be caused by FAODs.
• Beta-oxidation has also drawn attention in relation to metabolic
syndrome and obesity.
• The buildup of fatty acids in non-adipose tissues including the liver and
skeletal muscles can cause insulin resistance, inflammation, and the
emergence of metabolic diseases.
• This accumulation can be attributed to dysregulation of fatty acid
metabolism and defective beta-oxidation.
Digestion and Absorption of Lipids
Lipids are large molecules and generally are not water-soluble. Like carbohydrates and protein, lipids
are broken into small components for absorption. Since most of our digestive enzymes are water-
based, how does the body break down fat and make it available for the various functions it must
perform in the human body?

From the Mouth to the Stomach

The first step in the digestion of triacylglycerols and phospholipids begins in the mouth as lipids
encounter saliva. Next, the physical action of chewing coupled with the action of emulsifiers enables
the digestive enzymes to do their tasks. The enzyme lingual lipase, along with a small amount of
phospholipid as an emulsifier, initiates the process of digestion. These actions cause the fats to
become more accessible to the digestive enzymes. As a result, the fats become tiny droplets and
separate from the watery components.

[Link]

Figure

: Lipid Digestion

In the stomach, gastric lipase starts to break down triacylglycerols into diglycerides and fatty acids.
Within two to four hours after eating a meal, roughly 30 percent of the triacylglycerols are converted
to diglycerides and fatty acids. The stomach’s churning and contractions help to disperse the fat
molecules, while the diglycerides derived in this process act as further emulsifiers. However, even
amid all of this activity, very little fat digestion occurs in the stomach.

Going to the Bloodstream

As stomach contents enter the small intestine, the digestive system sets out to manage a small
hurdle, namely, to combine the separated fats with its own watery fluids. The solution to this hurdle
is bile. Bile contains bile salts, lecithin, and substances derived from cholesterol so it acts as an
emulsifier. It attracts and holds on to fat while it is simultaneously attracted to and held on to by
water. Emulsification increases the surface area of lipids over a thousand-fold, making them more
accessible to the digestive enzymes.

Once the stomach contents have been emulsified, fat-breaking enzymes work on the triacylglycerols
and diglycerides to sever fatty acids from their glycerol foundations. As pancreatic lipase enters the
small intestine, it breaks down the fats into free fatty acids and monoglycerides. Yet again, another
hurdle presents itself. How will the fats pass through the watery layer of mucous that coats the
absorptive lining of the digestive tract? As before, the answer is bile. Bile salts envelop the fatty
acids and monoglycerides to form micelles. Micelles have a fatty acid core with a water-soluble
exterior. This allows efficient transportation to the intestinal microvillus. Here, the fat components
are released and disseminated into the cells of the digestive tract lining.

Figure

: Fats can travel through the watery environment of

the body due to the process of emulsion.

Just as lipids require special handling in the digestive

tract to move within a water-based environment,
they require similar handling to travel in the
bloodstream. Inside the intestinal cells, the
monoglycerides and fatty acids reassemble
themselves into triacylglycerols. Triacylglycerols,
cholesterol, and phospholipids form lipoproteins
when joined with a protein carrier. Lipoproteins
have an inner core that is primarily made up of
triacylglycerols and cholesterol esters (a cholesterol
ester is a cholesterol linked to a fatty acid). The outer envelope is made of phospholipids
interspersed with proteins and cholesterol. Together they form a chylomicron, which is a large
lipoprotein that now enters the lymphatic system and will soon be released into the bloodstream via
the jugular vein in the neck. Chylomicrons transport food fats perfectly through the body’s water-
based environment to specific destinations such as the liver and other body tissues.

Cholesterols are poorly absorbed when compared to phospholipids and triacylglycerols. Cholesterol
absorption is aided by an increase in dietary fat components and is hindered by high fiber content.
This is the reason that a high intake of fiber is recommended to decrease blood cholesterol. Foods
high in fiber such as fresh fruits, vegetables, and oats can bind bile salts and cholesterol, preventing
their absorption and carrying them out of the colon.
If fats are not absorbed properly as is seen in some medical conditions, a person’s stool will contain
high amounts of fat. If fat malabsorption persists the condition is known as steatorrhea. Steatorrhea
can result from diseases that affect absorption, such as Crohn’s disease and cystic fibrosis.

The Truth about Storing and Using Body Fat

Before the prepackaged food industry, fitness centers, and weight-loss programs, our ancestors
worked hard to even locate a meal. They made plans, not for losing those last ten pounds to fit into
a bathing suit for vacation, but rather for finding food. Today, this is why we can go long periods
without eating, whether we are sick with a vanished appetite, our physical activity level has
increased, or there is simply no food available. Our bodies reserve fuel for a rainy day.

One way the body stores fat involves the body transforms carbohydrates into glycogen that is in turn
stored in the muscles for energy. When the muscles reach their capacity for glycogen storage, the
excess is returned to the liver, where it is converted into triacylglycerols and then stored as fat.

In a similar manner, much of the triacylglycerols the body receives from food is transported to fat
storehouses within the body if not used for producing energy. The chylomicrons are responsible for
shuttling the triacylglycerols to various locations such as the muscles, breasts, external layers under
the skin, and internal fat layers of the abdomen, thighs, and buttocks where they are stored by the
body in adipose tissue for future use. How is this accomplished? Recall that chylomicrons are large
lipoproteins that contain a triacylglycerol and fatty-acid core. Capillary walls contain an enzyme
called lipoprotein-lipase that dismantles the triacylglycerols in the lipoproteins into fatty acids and
glycerol, thus enabling these to enter into the adipose cells. Once inside the adipose cells, the fatty
acids and glycerol are reassembled into triacylglycerols and stored for later use. Muscle cells may
also take up the fatty acids and use them for muscular work and generating energy. When a person’s
energy requirements exceed the amount of available fuel presented from a recent meal or extended
physical activity has exhausted glycogen energy reserves, fat reserves are retrieved for energy
utilization.

As the body calls for additional energy, the adipose tissue responds by dismantling its triacylglycerols
and dispensing glycerol and fatty acids directly into the blood. Upon receipt of these substances the
energy-hungry cells break them down further into tiny fragments. These fragments go through a
series of chemical reactions that yield energy, carbon dioxide, and water.

Digestion and Absorption of Carbohydrates

 Lipids are transported by lipoproteins
in the blood and by lipid transfer proteins and vesicles within cells to deliver energy,
form membranes, and carry other essential functions. In the blood, specialized
protein-lipid complexes called lipoproteins,
including chylomicrons, VLDL, LDL, and HDL, transport lipids from the intestines and
liver to tissues and cells for use or storage. Inside cells, lipid transfer proteins
(LTPs) and lipid-carrying vesicles move lipids between different cellular membranes,
enabling proper membrane formation and function.
Lipid Transport in the Blood (Extracellular)
• Lipoproteins
are the primary carriers of lipids in the bloodstream because lipids are insoluble in
water.
• Structure of Lipoproteins:
These particles have a core of hydrophobic lipids (like triglycerides and cholesterol
esters) surrounded by a surface layer of phospholipids, cholesterol, and proteins
called apolipoproteins.
• Key Lipoproteins:
• Chylomicrons: Form in the small intestine to transport dietary triglycerides to the
body and adipose tissue.
• Very-Low-Density Lipoproteins (VLDL): Synthesized in the liver and transport
triglycerides to peripheral tissues.
• Low-Density Lipoproteins (LDL): Also known as "bad cholesterol," LDL
transports cholesterol to peripheral tissues.
• High-Density Lipoproteins (HDL): The "good cholesterol," HDL is involved in
reverse cholesterol transport, bringing excess cholesterol back to the liver.
• Mechanism:
Enzymes like lipoprotein lipase on the surface of cells break down triglycerides in
chylomicrons, allowing fatty acids and glycerol to enter cells for energy or storage.
Lipid Transport within Cells (Intracellular)
• Necessity:
Lipids are synthesized in specific cellular compartments and must be moved to
other locations for functions like membrane biogenesis.
• Mechanisms:
• Vesicular Trafficking: Lipid molecules are packaged into membrane-bound
vesicles that bud off from one membrane and fuse with another, delivering the
lipids to their destination.
• Lipid Transfer Proteins (LTPs): These proteins directly bind to specific lipid
molecules and transfer them from one membrane to another, such as for the
transport of plasma cholesterol into cells.
• Direct Membrane Contact: Lipids can also be transferred directly between
membranes that are in close proximity to each other.

Lipid metabolism disorders significantly contribute to atherosclerosis by causing

abnormal levels of blood lipids, particularly elevated LDL cholesterol and
triglycerides (TGs), and reduced HDL cholesterol. These imbalances trigger an
inflammatory response within artery walls, leading to the accumulation of lipids in the
arterial intima, formation of fatty streaks, and eventually the development of complex
atherosclerotic plaques that can lead to heart attacks and strokes.
How Lipid Metabolism Disorders Lead to Atherosclerosis
1. LDL Cholesterol Accumulation:
High levels of low-density lipoprotein (LDL) cholesterol, often referred to as "bad"
cholesterol, are a major risk factor. LDL particles transport cholesterol to peripheral
tissues; however, when in excess, they infiltrate the artery wall, initiating the
process of plaque formation.
2. HDL Cholesterol Reduction:
High-density lipoprotein (HDL) cholesterol, known as "good" cholesterol, helps
transport excess cholesterol from the arteries back to the liver for excretion. Low
HDL levels hinder this reverse cholesterol transport, promoting plaque buildup.
3. Triglyceride (TG) Dysregulation:
 High levels of triglycerides, a type of fat in the blood, are also associated with an
increased risk of atherosclerosis and are often seen with metabolic syndrome and
type 2 diabetes.
4. Inflammation and Foam Cell Formation:
The excess lipid accumulation, particularly of oxidized LDL (ox-LDL), triggers a
chronic inflammatory response in the artery wall. Macrophages engulf these
oxidized lipids, transforming into foam cells. These foam cells are a hallmark of
fatty streaks, the early stage of atherosclerotic plaques.
5. Plaque Progression:
Over time, these fatty streaks develop into mature, fibrous plaques, which can
narrow or block arteries, leading to serious cardiovascular events like heart attacks
and strokes.
Key Factors Involved
• Liver Dysfunction:
The liver is a central organ for lipid metabolism, and its dysfunction in processing
fats and producing lipoproteins is closely linked to the development of
atherosclerosis.
• Inflammation:
The interaction between abnormal lipid metabolism and the body's inflammatory
response is fundamental to atherosclerosis.
• Gut Microbiota:
Alterations in gut bacteria can also influence hepatic lipid metabolism, contributing
to the link between lipid metabolism disorders and atherosclerosis.
Managing Lipid Disorders for Prevention
• Statins:
Medications like statins are a primary treatment to lower LDL cholesterol and
reduce the risk of cardiovascular events.
• Lifestyle Changes:
A heart-healthy lifestyle, including a balanced diet and regular exercise, can help
manage lipid levels.
• Addressing Underlying Conditions:
Treating underlying conditions such as diabetes, which often lead to secondary
lipid metabolism disorders, is crucial.